This summary was created by AI, based on 5 opinions in the last 12 months.
Boston Scientific Corp (BSX) is gaining attention for its robust performance in the medical device sector, particularly due to the increasing demand driven by an aging population. The company has reported strong financial metrics, including a significant revenue beat and impressive organic growth of over 14.7%. Experts note that BSX has experienced solid momentum recently, buoyed by a favorable competitive landscape, such as Johnson & Johnson pausing a competing device. However, despite the positive outlook and expectations of double-digit growth, valuations are considered high, with a forward P/E of 37x. Thus, while it is viewed as a strong long-term investment, analysts recommend being cautious with aggressive buying at the current price levels.
BSX has seen solid momentum recently due to an acceleration in revenue along with a decent track record of acquisitive growth. BSX is trading at 37x Forward P/E and growth is expected to be around 9% in the next few years. That being said, valuation is not cheap. We feel it is a decent name to own over the long term, but we would not be adding aggressively at the current valuation. we are comfortable averaging into BSX over time given the premium valuation it is trading at.
Unlock Premium - Try 5i Free
Boston Scientific Corp is a American stock, trading under the symbol BSX-N on the New York Stock Exchange (BSX). It is usually referred to as NYSE:BSX or BSX-N
In the last year, 5 stock analysts published opinions about BSX-N. 5 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Boston Scientific Corp.
Boston Scientific Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Boston Scientific Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
5 stock analysts on Stockchase covered Boston Scientific Corp In the last year. It is a trending stock that is worth watching.
On 2025-04-11, Boston Scientific Corp (BSX-N) stock closed at a price of $93.67.
Likes the sector, not getting hit as hard today as many other things. Aging population will propel demand for medical devices such as stents, which this company is known for.